Of the many cytokines detectable in the peripheral blood during CRS, Interleukin-6 levels correlate most closely with disease severity (65), and IL-6 inhibition is effective therapy for severe CRS (64). This evidence concerns the gene IL6 and congenital rubella syndrome.